Substantial portion of cancer patients in early trials access drugs that are later approved, study finds
Credit: Pixabay/CC0 Public Domain A paper in the Journal of the National Cancer Institute finds that almost 20% of patients ...
Credit: Pixabay/CC0 Public Domain A paper in the Journal of the National Cancer Institute finds that almost 20% of patients ...
Even slight weight loss spurred on by cutting-edge GLP-1 drugs can help prevent replacement knees and hips from wearing out, ...
Ozempic and others in a new class of weight-loss drugs have been called “the medical sensation of the decade.” Are ...
Given the remarkable advances seen with gene therapies for sickle cell disease (SCD), it may seem counterintuitive to suggest the ...
Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them ...
WASHINGTON — Robert F. Kennedy Jr., President Trump’s pick to lead the Department of Health and Human Services, doesn’t think ...
The U.S. Department of Health and Human Services unveiled 15 additional drugs chosen for the Medicare Drug Price Negotiation Program ...
After a lengthy investigation, South African regulators decided Vertex Pharmaceuticals has sufficiently provided access to its cystic fibrosis medications, ending ...
Credit: Pixabay/CC0 Public Domain The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular ...
Over decades, antibodies have established themselves as a key therapeutic modality for a wide range of diseases. But antibodies as ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.